Tesla's Full Self-Driving Faces Divergent Paths in U.S. and Europe

Tesla's FSD tech faces a US safety probe and EU approval delay. Q1 2026 delivery estimates are cut sharply amid weak demand, pressuring cash flow for its $20B investment plan.

Tesla investors are navigating a complex landscape as the company’s flagship Full Self-Driving (FSD) technology encounters starkly different regulatory climates on opposite sides of the Atlantic. This comes amid mounting pressure from weakening delivery estimates for the first quarter of 2026.

U.S. Regulators Deepen Probe as European Approval Nears

In a significant development, the U.S. National Highway Traffic Safety Administration (NHTSA) has escalated its investigation into Tesla’s FSD system. The probe, encompassing approximately 3.2 million vehicles, was prompted by nine crashes where the system allegedly failed to adequately account for visual obstructions such as sun glare, fog, or dust. Analysts at GLJ Research have indicated this investigation represents the final stage before a potential mandatory recall—a scenario that could challenge the valuation premium associated with Tesla’s autonomous driving ambitions.

Conversely, in Europe, Tesla’s subsidiary has formally concluded the final testing phase for FSD (Supervised) with the Dutch vehicle authority, RDW, and submitted all required documentation. While this marks procedural progress, the anticipated approval date has been postponed once more, moving from late March to April 10. If granted, the Dutch certification could be nationally adopted by other EU member states under mutual recognition rules, with a union-wide approval anticipated by summer.

Delivery Estimates Cut Amid Broader Market Softness

The regulatory uncertainty coincides with concerning signals from Tesla’s core automotive business. UBS analyst Joseph Spak has reduced his delivery forecast for Q1 2026 to 345,000 vehicles. This figure represents an 18% decline from the previous quarter and falls 7% below the current market consensus. The downward revision is attributed to fading demand in the critical U.S. and Chinese markets, alongside a generally softer environment for electric vehicles. UBS maintains its sell rating on Tesla stock with a price target of $352.

Weaker deliveries strike at a sensitive point for the company. The automotive division is the primary generator of operational cash flow, which in turn funds an ambitious $20 billion investment program for 2026. This capital expenditure covers projects ranging from robotaxis and the humanoid Optimus robot to the Dojo supercomputer.

Analyst Sentiment and Forthcoming Catalysts

Market sentiment reflects this cautious outlook. Among the 34 analysts covering Tesla, ten currently recommend selling the shares—an unusually high proportion for a large-capitalization stock. The average price target among analysts stands at $383, which is nearly equivalent to the stock’s recent trading level.

The coming weeks are poised to deliver crucial data points for investors. Tesla will announce its official Q1 delivery numbers on April 2, providing a concrete measure of the demand slowdown. This will be followed by the quarterly earnings report on April 28, where margin performance will be a key focus. Sandwiched between these dates, the RDW’s decision on April 10 will determine whether Tesla can finally secure its first regulatory milestone for FSD in Europe.